Plasma Circulating Cell-free Nuclear and Mitochondrial DNA as Potential Biomarkers in the Peripheral Blood of Breast Cancer Patients
Authors:
- Enas H MahmoudEMEnas H Mahmoud
- Amal FawzyAFAmal Fawzy
- Omar K AhmadOAOmar K Ahmad
- Amr M AliAAAmr M Ali
Open Access
- 11 January 2016
- journal article
- research article
- Published by Asian Pacific Organization for Cancer Prevention in Asian Pacific Journal of Cancer Prevention
- Vol. 16 (18) , 8299-8305
Abstract
Plasma Circulating Cell-free Nuclear and Mitochondrial DNA as Potential Biomarkers in the Peripheral Blood of Breast Cancer Patients Breast cancer;ccf nuclear DNA;ccf mitochondrial DNA;diagnostic markers; Background: In Egypt, breast cancer is estimated to be the most common cancer among females. It is also a leading cause of cancer-related mortality. Use of circulating cell-free DNA (ccf-DNA) as non-invasive biomarkers is a promising tool for diagnosis and follow-up of breast cancer (BC) patients. Objective: To assess the role of circulating cell free DNA (nuclear and mitochondrial) in diagnosing BC. Materials and Methods: Multiplex real time PCR was used to detect the level of ccf nuclear and mitochondrial DNA in the peripheral blood of 50 breast cancer patients together with 30 patients with benign lesions and 20 healthy controls. Laboratory investigations, histopathological staging and receptor studies were carried out for the cancer group. Receiver operating characteristic curves were used to evaluate the performance of ccf-nDNA and mtDNA. Results: The levels of both nDNA and mtDNA in the cancer group were significantly higher in comparison to the benign and the healthy control group. There was a statistically significant association between nDNA and mtDNA levels and well established prognostic parameters; namely, histological grade, tumour stage, lymph node status andhormonal receptor status. Conclusions: Our data suggests that nuclear and mitochondrial ccf-DNA may be used as non-invasive biomarkers in BC.Keywords
This publication has 38 references indexed in Scilit:
- Mitochondrial DNA Copy Number Is Associated with Breast Cancer RiskPLOS ONE, 2013
- Analysis of Circulating Tumor DNA to Monitor Metastatic Breast CancerNew England Journal of Medicine, 2013
- Mitochondrial DNA content and mass increase in progression from normal to hyperplastic to cancer endometriumBMC Research Notes, 2012
- Genomic analysis of circulating cell-free DNA infers breast cancer dormancyGenome Research, 2011
- Apoptosis-related deregulation of proteolytic activities and high serum levels of circulating nucleosomes and DNA in blood correlate with breast cancer progressionBMC Cancer, 2011
- Molecular Imaging in Breast Cancer – Potential Future AspectsBreast Care, 2011
- Decreased mitochondrial DNA content in blood samples of patients with stage I breast cancerBMC Cancer, 2009
- Performance of mitochondrial DNA mutations detecting early stage cancerBMC Cancer, 2008
- Circulating mutant DNA to assess tumor dynamicsNature Medicine, 2008
- The prognostic significance of determining DNA content in breast cancer by DNA image cytometry: the role of high grade aneuploidy in node negative breast cancerJournal of Clinical Pathology, 2007